SS
AZN icon

Simplicity Solutions’s AstraZeneca AZN Stock Holding History

Simplicity Solutions’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$4.54M Buy
33,688
+3,520
+12% +$458K 0.12% 150
2023
Q3 		$4.09M Sell
30,168
-3,223
-10% -$440K 0.13% 143
2023
Q2 		$4.78M Buy
33,391
+1,177
+4% +$173K 0.13% 150
2023
Q1 		$4.47M Buy
32,214
+15,143
+89% +$2.04M 0.12% 160
2022
Q4 		$2.31M Buy
17,071
+634
+4% +$79.5K 0.31% 64
2022
Q3 		$1.8M Buy
16,437
+2,490
+18% +$316K 0.26% 78
2022
Q2 		$1.84M Buy
13,947
+2,788
+25% +$366K 0.24% 99
2022
Q1 		$1.48M Sell
11,159
-8,961
-45% -$1.07M 0.18% 121
2021
Q4 		$2.34M Buy
20,120
+11,148
+124% +$1.31M 0.26% 93
2021
Q3 		$1.08M Buy
8,972
+1,453
+19% +$169K 0.17% 133
2021
Q2 		$901K Buy
7,519
+1,217
+19% +$134K 0.18% 126
2021
Q1 		$627K Sell
6,302
-16,050
-72% -$1.61M 0.14% 164
2020
Q4 		$2.23M Buy
22,352
+8,573
+62% +$908K 0.03% 364
2020
Q3 		$1.51M Sell
13,779
-58
-0.4% -$6.45K 0.03% 401
2020
Q2 		$1.46M Buy
13,837
+616
+5% +$63.6K 0.03% 368
2020
Q1 		$1.18M Sell
13,221
-10,374
-44% -$977K 0.04% 311
2019
Q4 		$2.35M Buy
23,595
+5,816
+33% +$548K 0.07% 219
2019
Q3 		$1.58M Sell
17,779
-2,570
-13% -$223K 0.06% 216
2019
Q2 		$1.68M Buy
20,349
+9,443
+87% +$740K 0.07% 180
2019
Q1 		$882K Buy
10,906
+2,647
+32% +$209K 0.05% 270
2018
Q4 		$628K Sell
8,259
-8,794
-52% -$687K 0.08% 265
2018
Q3 		$1.35M Buy
17,053
+5,005
+42% +$379K 0.08% 142
2018
Q2 		$846K Buy
12,048
+907
+8% +$65.3K 0.06% 172
2018
Q1 		$779K Sell
11,141
-1,666
-13% -$115K 0.07% 160
2017
Q4 		$888K Buy
12,807
+8,984
+235% +$606K 0.09% 152
2017
Q3 		$259K Sell
3,823
-6,359
-62% -$402K 0.17% 165
2017
Q2 		$694K Sell
10,182
-849
-8% -$55.4K 0.08% 207
2017
Q1 		$687K Buy
11,031
+5,705
+107% +$332K 0.11% 192
2016
Q4 		$291K Buy
+5,326
New +$302K 0.07% 264

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplicity Solutions's AZN Position: Q4 2023 in Review

Simplicity Solutions increased its AstraZeneca (AZN) stake by 12% in Q4 2023, buying an estimated $458K and bringing the position to 33,688 shares worth $4.54M. The position accounts for 0.12% of the portfolio, ranked #150.

Simplicity Solutions first reported a position in AZN in Q4 2016 and has held it in 29 quarters since. The position peaked at $4.78M in Q2 2023. 1,130 funds tracked by Wall St. Rank hold AZN as of Q4 2023.

  • Simplicity Solutions held 33,688 shares of AstraZeneca worth $4.54M as of Q4 2023.
  • Simplicity Solutions bought 3,520 AstraZeneca shares in Q4 2023, an estimated $458K.
  • AstraZeneca made up 0.12% of Simplicity Solutions's portfolio in Q4 2023, its #150 holding.
  • Simplicity Solutions first reported a position in AstraZeneca in Q4 2016 and has held it in 29 quarters since.
  • Simplicity Solutions's AstraZeneca position peaked at $4.78M in Q2 2023.
  • 1,130 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.